Back

Cardiac amyloidosis and left atrial appendage closure: a multicenter retrospective study

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Left atrial appendix closure for stroke prevention in atrial fibrillation Left Atrial Appendage Closure ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Edward El-Am

Mayo Clinic, Rochester (United States of America)

6 More presentations in this session

Presentation thumbnail
Incidence and predictors of 2-year mortality following percutaneous left atrial appendage occlusion in the EWOLUTION tria
Mr E. Aarnink (Nieuwegein, NL)
Abstract Slides Video
Presentation thumbnail
Prevention of thromboembolic events in atrial fibrillation patients with persistent leaks following the watchman implantation
Doctor S. Mohanty (Austin, US)
Abstract Slides Video
Presentation thumbnail
Safety of left atrial appendage amputation during cardiothoracic surgery
Mr M. Terpstra (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Combined PVI and LAAC is feasible using RFA or PFA in a canine model despite acute tissue edema in PFA versus RFA
Doctor W. Saliba (Cleveland, US)
Abstract Slides Video
Presentation thumbnail
Impact of left atrial appendage occlusion in atrial flow evaluated through 4D flow cardiac magnetic resonance
Mr I. Anduaga Elorza (Barcelona, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Left atrial appendix closure for stroke prevention in atrial fibrillation

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Direct oral anticoagulants versus warfarin for atrial fibrillation in patients with transthyretin cardiac amyloidosis: a retrospective cohort analysis
thumbnail
Congress Presentation
Atrial dysfunction in isolated atrial amyloidosis: a pathological and echocardiographic perspectives
thumbnail
Congress Presentation
Safety and efficacy of catheter ablation in patients with atrial arrhythmias and cardiac amyloidosis: a systematic review and meta-analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources